Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.61 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.61 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.61 |
| ▸ | HTR3B | O95264 | 1/20 | 0.61 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.61 |
| ▸ | HTR3A | P46098 | 1/20 | 0.61 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.61 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18228234 | 1.00 | L3MBTL1 (0.61) | L3MBTL1MBTD1L3MBTL3LMNASIGMAR1 | |
| Benzene SCHEMBL28818227 | 0.97 | L3MBTL1 (0.59) | L3MBTL1MBTD1L3MBTL3LMNASIGMAR1 | |
| Water SCHEMBL3988826 | 0.97 | L3MBTL1 (0.59) | L3MBTL1MBTD1L3MBTL3LMNASIGMAR1 | |
| Hydrochloric Acid SCHEMBL5576496 | 0.97 | L3MBTL1 (0.59) | L3MBTL1MBTD1L3MBTL3LMNASIGMAR1 | |
| SCHEMBL93630 | 0.97 | L3MBTL1 (0.59) | L3MBTL1MBTD1L3MBTL3LMNASIGMAR1 | |
| SCHEMBL2312380 | 0.97 | L3MBTL1 (0.59) | L3MBTL1MBTD1L3MBTL3LMNASIGMAR1 | |
| SCHEMBL8542780 | 0.97 | L3MBTL1 (0.59) | L3MBTL1MBTD1L3MBTL3LMNASIGMAR1 | |
| SCHEMBL1968506 | 0.97 | L3MBTL1 (0.59) | L3MBTL1MBTD1L3MBTL3LMNASIGMAR1 | |
| SCHEMBL30885369 | 0.97 | L3MBTL1 (0.59) | L3MBTL1MBTD1L3MBTL3LMNASIGMAR1 | |
| Hydrochloric Acid SCHEMBL5417163 | 0.95 | ALDH1A1 (0.60) | L3MBTL1MBTD1L3MBTL3LMNASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1475 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-119191983-A | Preparation method and application of sinapic acid ester compound | 中国科学院新疆理化技术研究所 | 2024-12-27 | — | — | CN | claimed |
| CN-118373822-B | Material containing benzopyrrole acridine structure and application thereof | 烟台九目化学股份有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-118373822-A | Material containing benzopyrrole acridine structure and application thereof | 烟台九目化学股份有限公司 | 2024-07-23 | — | — | CN | claimed |
| US-20240218022-A1 | ANTI-VISTA MACROCYCLIC PEPTIDES AND COMPOSITIONS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-04 | — | — | US | claimed |
| CN-118184520-A | Biphenyl amine compound, preparation method thereof and application thereof in flow battery | 中国科学院大连化学物理研究所 | 2024-06-14 | — | — | CN | claimed |
| CN-117866529-B | Nickel screen coating material, printed nickel screen, and preparation method and application thereof | 淮安天马纺织器材有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-118125962-A | Method for preparing 2-aminomethylindoline-3-carboxylic acid from carbon dioxide | 常州大学 | 2024-06-04 | — | — | CN | claimed |
| CN-117866529-A | Nickel screen coating material, printed nickel screen, and preparation method and application thereof | 淮安天马纺织器材有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117756856-A | Metal alkynyl binuclear copper complex and preparation method and application thereof | 中国科学院理化技术研究所 | 2024-03-26 | — | — | CN | claimed |
| EP-1244670-A1 | HYDANTOIN DERIVATIVE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USING SAME | GPI NIL Holdings, Inc. (US) | 2002-10-02 | — | — | EP | claimed |
| WO-2002068405-A1 | ORGANIC RED ELECTROLUMINESCENT CHROMOPHORES, METHOD FOR THE PRODUCTION AND USE THEREOF | SIEMENS AKTIENGESELLSCHAFT (DE) | 2002-09-06 | — | — | WO | claimed |
| JP-2002500641-A | — | — | 2002-01-08 | — | — | JP | claimed |
| WO-2001096339-A1 | NOVEL TELOMERASE INHIBITORS | PHARMACIA ITALIA S.P.A. (IT) | 2001-12-20 | — | — | WO | claimed |
| WO-2001046195-A1 | HYDANTOIN DERIVATIVE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USING SAME | GPI NIL HOLDINGS, INC. (US) | 2001-06-28 | — | — | WO | claimed |
| EP-0998451-A1 | SUBSTITUTED 3,3-DIAMINO-2-PROPENENITRILES, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 2000-05-10 | — | — | EP | claimed |
| WO-1998050344-A1 | SUBSTITUTED 3,3-DIAMINO-2-PROPENENITRILES, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1998-11-12 | — | — | WO | claimed |
| EP-0309913-B1 | Fungicidal N-substituted 3-aryl-pyrrolidine derivatives | BASF AG (DE) | 1994-06-15 | — | — | EP | claimed |
| EP-0188805-B1 | 1,3-DITHIOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-09-06 | — | — | EP | claimed |
| US-4808644-A | STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1989-02-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240218022-A1 | ANTI-VISTA MACROCYCLIC PEPTIDES AND COMPOSITIONS | VIP, SGTA, NGLY1 | L3MBTL1 1345/4885MBTD1 264/4885L3MBTL3 2694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.